clinical trials
-
Research updates, July 22
A treatment for cats with a COVID-related infection may help advance Long COVID research. In a small study in Stem Cells Translation Medicine, researchers treated 10 cats who got feline infectious peritonitis (FIP), a feline coronavirus infection that triggers immune dysfunction, and found that those who received a combination of the antiviral drug GS-441524 and…
-
Research updates, July 15
A new study in PNAS found elevated oxidative stress was a shared characteristic in both myalgic encephalomyelitis (ME) and Long COVID.
-
Research updates, July 8
The biotech company Invivyd, which makes the COVID-19 monoclonal antibody Pemgarda, announced this week that it has launched the SPEAR Study Group to explore the drug for Long COVID and post-vaccine syndrome (PVS).
-
Research updates, July 1
Scientists found a new antiviral drug prototype that prevented Long COVID in mice and could also help treat the disease. In a study describing this milestone, published in Nature Communications, researchers stated the antiviral targets the coronavirus’ PLpro protein, as opposed to the Mpro protein, which Paxlovid targets.
-
Research updates, June 24
A new review paper published in Psychiatry and Clinical Neurosciences focuses on how Long COVID impacts the nervous and immune systems, and describes it as a neuroimmune condition.
-
Still Here, June 12: Links and transcript
The Sick Times’ team recaps the Spring 2025 PolyBio Research Symposium on Long COVID. And disabled journalist Lygia Navarro talks about the language we use for Long COVID.
-
Research updates, June 10
Three recent studies show the harmful effects of misdiagnosis for chronic diseases and conditions. The first, a meta-analysis in Psychological Bulletin of 151 studies encompassing 11 diseases (including Long COVID) and over 11,000 participants, found that medical gaslighting led to adverse impacts including diagnostic delay and emotional stress.
-
Research updates, June 3
A new National Institutes of Health RECOVER program study in JAMA Pediatrics found that around one in seven children under age six with a prior SARS-CoV-2 infection met the probable diagnostic criteria for Long COVID. Studying over 1,000 infants, toddlers, and preschool-aged children, researchers revealed differences in how Long COVID presented between age groups.
-
Still Here, May 25: Links and transcript
Freelance journalist Kate Fishman on how games can offer a lens into the Long COVID experience. And science and medicine journalist Felicity Nelson talks about participating in a Long COVID clinical trial.
-
Research updates, May 20
Early results from a Long COVID clinical trial assessing the monoclonal antibody AER002 found no difference between those who got the drug and placebo. Researcher Michael Peluso revealed the results at the PolyBio Spring Symposium; he and his colleagues are still analyzing data and will publish a paper later.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance